Sinsinwar Simran, Vadivel Vellingiri
Chemical Biology Lab (ASK-II-409), School of Chemical and Biotechnology, SASTRA Deemed University, Thanjavur, Tamil Nadu, India.
Appl Microbiol Biotechnol. 2020 Oct;104(19):8279-8297. doi: 10.1007/s00253-020-10853-z. Epub 2020 Aug 28.
Staphylococcus aureus causes severe infections and among all methicillin-resistant S. aureus (MRSA) remains a great challenge in spite of decade research of antibacterial compounds. Even though some synthetic antibiotics have been developed, they are not effective against MRSA, and hence, there is a search for natural, alternative and plant-based antibacterial compound. In this connection, catechin isolated from cashew nut shell was investigated for its antibacterial potential against MRSA. Catechin exhibited zone of inhibition (ZOI) and minimum inhibitory concentration (MIC) in a range of 15.1-19.5 mm and 78.1-156.2 μg/ml, respectively, against ATCC and clinical isolates of MRSA. Among all clinical isolates, clinical isolate-3 exhibited highest sensitivity to catechin. Catechin has arrested the growth of MRSA strains and also caused toxicity by membrane disruption which was illustrated by AO/EB fluorescence staining. Increased nucleic acid leakage (1.58-28.6-fold) and protein leakage (1.40-23.50-fold) was noticed in MRSA due to catechin treatment when compared to methicillin. Bacteria treated with catechin at its MIC showed 1.52-, 1.87- and 1.74-fold increase of ROS production in methicillin susceptible S. aureus (MSSA), MRSA and clinical isolate-3 strains, respectively, as compared to control. Superoxide dismutase (5.31-9.63 U/mg protein) and catalase (1573-3930 U/mg protein) were significantly decreased as compared to control in catechin-treated S. aureus. Thus, catechin exhibited antibacterial activity through oxidative stress by increased production of ROS and decreased antioxidant enzymes. Altogether results suggest that catechin is a promising lead compound with antibacterial potential against MRSA. KEY POINTS: • Catechin was isolated and identified as active compound in cashew nut shell. • Catechin exhibited antimicrobial activity against clinical isolates of MRSA. • Bacterial cell wall damage was caused by catechin in MRSA strains. • Catechin increased the oxidative stress in MRSA by intracellular ROS production.
金黄色葡萄球菌可引发严重感染,尽管对抗菌化合物已进行了数十年研究,但在所有耐甲氧西林金黄色葡萄球菌(MRSA)中,它仍是一个巨大挑战。尽管已研发出一些合成抗生素,但它们对MRSA无效,因此,人们正在寻找天然、替代且基于植物的抗菌化合物。在此方面,对从腰果壳中分离出的儿茶素针对MRSA的抗菌潜力进行了研究。儿茶素对MRSA的ATCC菌株和临床分离株分别表现出15.1 - 19.5毫米的抑菌圈(ZOI)和78.1 - 156.2微克/毫升的最低抑菌浓度(MIC)。在所有临床分离株中,临床分离株 - 3对儿茶素表现出最高敏感性。儿茶素抑制了MRSA菌株的生长,还通过膜破坏导致毒性,这通过AO/EB荧光染色得以证明。与甲氧西林相比,儿茶素处理后的MRSA中核酸泄漏(增加1.58 - 28.6倍)和蛋白质泄漏(增加1.40 - 23.50倍)更为明显。与对照相比,用儿茶素在其MIC浓度处理的细菌在甲氧西林敏感金黄色葡萄球菌(MSSA)、MRSA和临床分离株 - 3菌株中分别使活性氧(ROS)产生增加了1.52倍、1.87倍和1.74倍。与对照相比,儿茶素处理的金黄色葡萄球菌中超氧化物歧化酶(5.31 - 9.63单位/毫克蛋白质)和过氧化氢酶(1573 - 3930单位/毫克蛋白质)显著降低。因此,儿茶素通过增加ROS产生和降低抗氧化酶,通过氧化应激表现出抗菌活性。总体结果表明,儿茶素是一种有前景的具有抗MRSA抗菌潜力的先导化合物。要点:• 儿茶素被分离并鉴定为腰果壳中的活性化合物。• 儿茶素对MRSA临床分离株表现出抗菌活性。• 儿茶素在MRSA菌株中导致细菌细胞壁损伤。• 儿茶素通过细胞内ROS产生增加MRSA中的氧化应激。